baber/WOPTO huggingface dataset:
Patent DK-2971898-T3 (DK)
Inventor: OGEN ITZHAK
IPC: F16K24/04
Filed: 2014-03-12
Granted: 2018-08-06
Abstract: A gas purge valve (20) comprising a housing (22) configured with float chamber (40) extending between a fluid inlet port (36) and a fluid outlet port (38), the float chamber accommodating a float- activated valve assembly (50) axially displaceable within the float chamber. The valve assembly comprising at least a kinetic sealing component (54) being axially displaceable within the housing between at least a closed position sealingly engaging a sealing seat (48) of the fluid outlet port, and an open position in which it is disengaged from the sealing seat. The fluid inlet port is in flow communication with the float chamber through a fluid inlet path configured with a fluid flow regulator (100) configured with a fluid discharge flow path (102). The arrangement is such that the minimal diameter of the fluid discharge flow path is greater than the diameter of at least a lower portion of the valve assembly.
Patent DK-3089979-T3 (DK)
Inventor: DILGER ANDREW K
IPC: A61P7/02
Filed: 2015-07-29
Granted: 2018-01-15
Abstract: The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
Patent DK-0440846-T3 (DK)
Inventor: VETTER UDO J
IPC: A61M5/31
Filed: 1990-02-07
Granted: 1993-07-12
Abstract: The invention relates to a syringe for medical purposes, with a syringe barrel (1) designed at the one end for the attachment of an injection needle (2), and with a syringe piston (3) which is displaceable in the syringe barrel (1), and with a stopper (4) which is arranged between the needle attachment end (5) and the syringe piston (3) and thus forms the two chambers (6, 7) of a two-chamber syringe. In the needle-side chamber (6) the circumferential surface of the syringe barrel (1) is provided with an axially extending cross-section widening which forms a bypass (8) and via which the two chambers (6, 7) are connected to one another when the stopper (4) is moved into the area of the bypass (8). A damping part (9) serving as a piston brake is arranged at the cylinder end lying opposite the needle attachment end (5), this damping part (9) cooperating with a stop device (13, 14) arranged on the piston rod (10) in such a way as to permit a complete and thorough mixing of active substance and solvent. 
<IMAGE>
Patent DK-0432419-T3 (DK)
Inventor: MCCOY KEVIN MICHAEL
IPC: C07K1/00
Filed: 1990-10-23
Granted: 1994-11-14
Abstract: The present invention relates to a process for solubilization and naturation of somatotropins utilizing a combination of low urea solution and an aqueous alkaline solution. By utilizing the process of the present invention, enhanced yields of end product result.
Patent DK-0392640-T3 (DK)
Inventor: GILMAN THOMAS
IPC: A61F13/02
Filed: 1990-04-12
Granted: 1995-10-30
Abstract: A dressing for a wound of a patient having, a base sheet (12) for contacting the skin of the patient, with the base sheet having an opening for placement over the wound. The dressing has a vent providing controlled leakage of fluid along a path from the wound through the opening of the base sheet.
Patent DK-0378354-T3 (DK)
Inventor: KUBIK MARIAN LESZEK
IPC: E04B1/19
Filed: 1990-01-09
Granted: 1994-04-11
Abstract: A space frame structure primarily for use as a floor comprises a steel space frame made up of an upper layer (11) of structural members (15), a lower layer (12) of structural members (16) and upright members (14) joining the upper and lower members. An upper concrete layer (50) is poured on to shuttering (41) so that the upper parts of upper structural members (15) are embedded in the concrete.
Patent DK-0421831-T3 (DK)
Inventor: LABAT YVES
IPC: C07B61/00
Filed: 1990-08-31
Granted: 1993-08-16
Abstract: Manufacture of esters of mercaptocarboxylic acids and of alcohols forming an azeotrope with water. 
<??>The esterification is carried out continuously in the presence of excess alcohol and the water formed is removed by azeotropic entrainment under vacuum at a temperature such that the concentration of residual water in the reaction mixture remains constantly lower than 0.5% by weight. 
<??>The process according to the invention applies more particularly to the synthesis of octyl esters of thioglycolic acid.
Patent DK-0466037-T3 (DK)
Inventor: RORSTAD GUNNAR
IPC: A61P31/00
Filed: 1991-07-04
Granted: 1998-08-10
Abstract: The present invention provides a process for stimulating the immune system of aquatic animals of the class Osteichthyes and subphylum Crustacea comprising administering an effective amount of a yeast cell wall glucan composed of glucopyranose units linked by predominately beta-1,3 glycosidic bonds, having at least one branch therefrom of glucopyranose units linked by beta-1,6 glycosidic bonds. Additionally the invention provides a process for enhancing the effect of vaccines by administering an effective amount of the described yeast cell wall glucan along with vaccine antigens. Further this invention also provides a process for obtaining a glucan particularly effective for stimulating the immune system of aquatic animals of the class Osteichthyes and subphylum Crustacea. <IMAGE>
Patent DK-0475392-T3 (DK)
Inventor: SAKASHITA NOBUYUKI
IPC: A01N43/90
Filed: 1991-09-11
Granted: 1996-07-22
Abstract: A herbicidal composition is disclosed, comprising, as active ingredients, 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl )urea or a salt thereof and at least one member selected from the group consisting of N-(phosphonomethyl)glycine, 1,1'-dimethyl-4,4'-bipyridinium ion, 1,1'-ethylene-2,2'-bipyridylium ion and salts thereof.
Patent DK-0476859-T3 (DK)
Inventor: HATT WALTER
IPC: B65H5/30
Filed: 1991-08-27
Granted: 1995-03-13
Abstract: A device for separating edges of a group of papers while the pages are being conveyed in a linear direction (7) has splitter (10), which divides the pages into approximately equal bundles. A pair of grippers (11) then holds the corners while a spiral or a generally cylindrical member (23) enters the opening between the bundles and carries it to the opposite side. The arms of the cylindrical member (23) is at an angle to said linear direction (7) greater than 0 DEG and less than 90 DEG . <IMAGE>
Patent DK-0476122-T3 (DK)
Inventor: MCBRIDE STEPHEN W
IPC: B65D41/34
Filed: 1991-04-02
Granted: 1996-02-05
Abstract: A tamper-indicating plastic closure for a container comprises a plastic closure cap having a circular top wall portion, and a depending annular skirt portion. The closure further includes an annular pilfer band depending from the skirt portion which is at least partially detachably connected thereto by a frangible connection. The pilfer band includes a plurality of circumferentially spaced flexible projections, and a plurality of respectively associated interference beads. By this arrangement, the pilfer band is configured for two modes of interfering engagement with an annular locking ring of an associated container for at least partially separating the pilfer band from the closure skirt for tamper-indication.
Patent DK-0537244-T3 (DK)
Inventor: SEBASTIANI ENRICO
IPC: F23D14/58
Filed: 1991-07-05
Granted: 1999-07-26
Abstract: PCT No. PCT/IT91/00056 Sec. 371 Date Dec. 28, 1992 Sec. 102(e) Date Dec. 28, 1992 PCT Filed Jul. 5, 1991 PCT Pub. No. WO92/01196 PCT Pub. Date Jan. 23, 1992.In a method of combustion designed to achieve a further reduction in harmful emissions, especially of NOx and CO, which is viable at advantageously reduced noise levels and lower cost with any burner of a type comprising a slotted or pierced diffuser of thin sheet metal in receipt of fully or partly mixed gas and air supplies, typically in appliances comprising a heat exchanger such as the boilers of central heating systems, the essential steps are: a) supplying a uniform flow of fuel-air mixture to the slots; b) discharging the mixture from a pierced surface of substantially doughnut geometry comprising a slotted peripheral area (Ap) and an essentially solid central area (Ac) of prescribed proportions; c) bringing combustion to completion in a slender lamellar flame; d) regulating the rate of aeration to a value between 0.9 and 1.4, or e) to values less than 1.6; f) effecting a recycle of post-combustion gases.
Patent DK-0501444-T3 (DK)
Inventor: KRIESE PETER
IPC: F28F9/02
Filed: 1992-02-26
Granted: 1996-04-09
Abstract: The invention relates to a radiator, preferably a radiating ceiling plate, made from a plurality of heat-exchanging elements which are situated next to one another and connected in parallel and/or behind one another on the side of a flowing medium, and whose supply and drainage is connected in each case to a continuous manifold in which elastic separating plugs, preferably made from rubber or plastic, are arranged in order to subdivide the manifold into individual line sections. In order to develop a radiator of the type described at the beginning so as to prevent undesired displacements of the separating plugs, the separating plugs (3) are fixed in a form-locking fashion against displacement in the manifold (2) by means of stop surfaces constructed in the interior of the manifold (2). <IMAGE>
Patent DK-0507234-T3 (DK)
Inventor: DECKWER WOLF-DIETER
IPC: C12N1/20
Filed: 1992-03-30
Granted: 2001-10-08
Abstract: The invention relates to a method for isolating cells, to a cell line obtained by this method, and to a method which makes use of isolated cells and which is directed at the efficient preparation of polysaccharides. <IMAGE>
Patent DK-0580888-T3 (DK)
Inventor: RENGER WOLFGANG DIPL-ING FH
IPC: H04M3/30
Filed: 1992-07-30
Granted: 1999-08-16
Abstract: Control arrangement of a test system, in which in a processor-controlled telecommunications system (K) a test unit control program module (TUC) arranged in a line trunk group (LTG) is connected to a unit under test (TA, TS, TL...) via a test unit (TU) subdivided into test modules (FTEM, LMEM, LVMM) and executes these procedures. The line-oriented test unit control program module (TUC) activated by a central control program module (TLFI) controls the routines for seizing and releasing the test unit (TU), to be executed in the test system. The test unit control program module (TUC) is entered in each of the device memory tables (DPS) belonging to the test unit (TU) and in each case executes a particular test procedure when called up. In the execution phase, the test unit control program module (TUC) remains in a defined state. The test routines are carried out and checked without active intervention of the test unit control program module (TUC). During the seizing and releasing phases, the test unit control program module (TUC) passes through certain (intermediate) states, the DPS status entries of the in each case passive programs being updated at the end. <IMAGE>
Patent DK-0507461-T3 (DK)
Inventor: REBELE DONALD J
IPC: A61L15/46
Filed: 1992-03-11
Granted: 1996-10-14
Abstract: The body portion (A) of a small portable sterilizer has a face panel (46) against which a door (B) is selectively closed. The face panel defines an access opening for a sterilization chamber (10) which receives a cassette (C), an access opening for an anti-microbial concentrate chamber (20) which receives a powdered or other sterilant concentrate, and an outlet opening (50) from a microbe filter which filters microbes from incoming rinse water. The face plate and the door define fluid flow channels (48, 52) therebetween for selectively directing sterilant solutions and rinse solutions among the anti-microbial concentrate chamber, the sterilization chamber, and the microbial filter. The cassette is configured to ensure that it is inserted into the sterilization chamber with a unique orientation such that its fluid inlet apertures (114) and outlet apertures (124) are at preselected locations. The door includes generally U-shaped projections (116) which abut an outer surface of the cassette in the sterilization chamber partially surrounding the fluid inlet apertures. The U-shaped projections ensure that the cassette is seated in the sterilization chamber and provide a well which directs the circulating fluids into the cassette inlet apertures. A pair of gaskets (56, 86) surround the active portion of the face panel. A vacuum pump (90) selectively draws a vacuum in an annular region (88) between the gaskets, which vacuum locks the door against the face plate in a sealed, closed position. To assure a fluid tight seal, the gaskets are O-rings which are pressed by the vacuum into V-shaped grooves (82, 84). <IMAGE>
Patent DK-0509761-T3 (DK)
Inventor: SZABO ANNA
IPC: A61K31/135
Filed: 1992-04-14
Granted: 1997-02-17
Abstract: The invention concerns an anhydrous transdermal preparation comprising in a 20-100% lyotropic liquid crystalline arrangement: 5-15 w.% of optically active or racemic N-methyl-N-(phenyl-2-propyl)-2-propynylamine or N-methyl-N-(1-(4-fluoro-phenyl)-2-propyl)-2-propynylamine or their therapeutically acceptable salts,     40-70 w.% of liquid polyoxyethyleneglycol,     10-20 w.% of solid polyoxyethyleneglycol,     2-30 w.% of a nonionic surface active agent,     2-20 w.% of propyleneglycol, if desired 0.5-2 w.% of a polymer the a value of which is > 0.6, and if desired other auxiliary agents.
Patent DK-0532348-T3 (DK)
Inventor: MARYANOFF CYNTHIA A
IPC: A61P25/04
Filed: 1992-09-11
Granted: 1996-02-05
Abstract: This invention relates to a tramadol N-oxide material, enantiomers and compositions thereof and their use. The tramadol N-oxide material and compositions thereof are pharmacologically useful in treating pain, diarrhea and tussive conditions. The tramadol N-oxide is also subject to less side-effects as compared to pure opiate based compositions, such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, the tramadol N-oxide material when administered orally exhibits analgesia for a longer duration than an equi-analgesic amount of tramadol.
Patent DK-0541443-T3 (DK)
Inventor: ANSEL DENIS
IPC: A61F2/82
Filed: 1992-11-05
Granted: 1996-06-03
Abstract: The subject of the present invention is an endoprosthesis consisting of the alternate juxtaposition of axially rigid cylindrical parts (1, 1') and at least one axially flexible cylindrical part (2); the said endoprosthesis comprising axially rigid cylindrical parts (1, 1') at its two ends; the said axially rigid cylindrical parts (1, 1') being capable of plastic radial expansion, and the said axially flexible cylindrical part(s) (2) being capable of elastic radial expansion. Such an endoprosthesis has adjustable axial flexibility and length. <IMAGE>
Patent DK-0563133-T3 (DK)
Inventor: EVANS CHRISTOPHER THOMAS
IPC: A23K1/165
Filed: 1991-12-16
Granted: 1996-01-15
Abstract: PCT No. PCT/GB91/02246 Sec. 371 Date Aug. 13, 1993 Sec. 102(e) Date Aug. 13, 1993 PCT Filed Dec. 16, 1991 PCT Pub. No. WO92/10945 PCT Pub. Date Jul. 9, 1992.A formulation consisting essentially of -1,4-xylanase and -1,3-xylosidase, but essentially free of -1,4-glucanase and -1,4-cellobiohydrolase and on or more lactic acid-producing bacteria is disclosed. The formulation can be used in a silage composition to stabilize silage from cereal and other crops and to enhance its nutritive value and digestibility in a ruminant or other animal.
Patent DK-0646115-T3 (DK)
Inventor: VILLALOBOS ANABELLA
IPC: C07D/
Filed: 1992-03-09
Granted: 2003-04-22
Abstract: Compounds of formula (I) wherein R<1>, R<2>, R<7>, R<8>, X, Y, M and L are defined as below. The compounds of formula (I) are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.
Patent DK-0669853-T3 (DK)
Inventor: HEMMINGS PAUL NICHOLAS
IPC: C09K23/34
Filed: 1993-11-15
Granted: 1996-12-30
Abstract: PCT No. PCT/SE93/00970 Sec. 371 Date May 16, 1995 Sec. 102(e) Date May 16, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/12272 PCT Pub. Date Jun. 9, 1994Surfactant obtainable by and method for the production thereof comprising (1) esterifying a rosin with an alcohol to an acid value of less than 30, (2a) grafting the rosin ester with an unsaturated carboxylic acid or anhydride, the mole ratio carboxylic acid or anhydride/rosin (calculated as each rosin associated with a rosin ester) being from 0.05:1-1.5:1, (3a) esterifying the grafted rosin ester with a polyethylene glycol with an Mw of 1000-20000 the mole ratio glycol/free carboxylic acid group being from 0.2:1-1:1 to an acid value of less than 30, alternatively (2b) esterifying an unsaturated carboxylic acid or anhydride with a polyethylene glycol with a Mw of 1000-20000 the mole ratio glycol/free carboxylic acid group or anhydride being from 0.2:1-1:1 to an acid value less than 30, (3b) grafting the rosin ester from (1) with the ester from (2b), the mole ratio ester from (2b)/rosin ester (calculated as in (2a)) being from 0.05:1-1.5:1. The invention also relates to the use of the surfactant as a dispersing agent for tackifiers, to an aqueous tackifier dispersion comprising the surfactant as well as to the use of the aqueous tackifier dispersion in a pressure sensitive adhesive.
Patent DK-0698041-T3 (DK)
Inventor: MALABARBA ADRIANO
IPC: A61P31/04
Filed: 1994-04-14
Granted: 1997-12-08
Abstract: PCT No. PCT/EP94/01154 Sec. 371 Date Dec. 26, 1995 Sec. 102(e) Date Dec. 26, 1995 PCT Filed Apr. 14, 1994 PCT Pub. No. WO94/26780 PCT Pub. Date Nov. 24, 1994Synthetic aglucodalbaheptides of formula (I) wherein W and Z, each independently, represent the relative portions of the aglycon of an antibiotic of the dalbaheptide group. Y represents a carboxylic group or a functional derivative of said carboxylic group; R and R1, each independently, represent hydrogen or a protecting group of the amino function. R2 represents hydrogen; and their salts with acid and bases as well as their inner salts. A process for producing the aglucodabaheptides of formula (I) and their use as medicaments.
Patent DK-0699256-T3 (DK)
Inventor: HESELIUS LARS-HENRIK
IPC: E04C2/292
Filed: 1994-05-19
Granted: 1999-10-18
Abstract: The present invention is related to a joint structure for sandwich panels comprised of a mineral wool core (1) which is advantageously clad on both sides by skin sheets (2) bonded to the mineral wool core. The mineral wool core (1) is left bare on the edge remaining between a groove-and-tongue structure (3, 3') included in the skin sheet structure to accomplish the mating of the surfaces of the mineral wool core of the panels to be jointed. To assure the tightness of the joint, the mineral wool core (1) is at the area of the tongue-and-groove joint subjected to a higher compressive contraction in the mating direction of the panels than elsewhere in the core after the skin sheet structures of the panels are pushed home in their tongue-and-groove joints.
Patent DK-0698091-T3 (DK)
Inventor: FELICI FRANCO
IPC: C12N15/10
Filed: 1994-05-05
Granted: 1999-06-07
Abstract: A process for the preparation of immunogens or diagnostic reagents that mimic an antigen or a pathogenic organism specific to a disease, essentially characterized by the following operations: identification of at least one antibody that reacts with the antigen or pathogenic organism specific to the disease; construction of phage libraries which display on the surface of the capsid oligopeptides, expressed from random sequence oligonucleotidic inserts introduced into a gene coding for a phage capsid protein using genetic manipulation techniques (for example, using a plasmid engineered for the purposes of the invention, the genetic map of which is shown in the figure); selection of the phages that display on the surfaces of the capsid antigenic oligopeptides recognized by said antibody; optional use of the selected phages and/or fragments thereof and/or their derivatives for the formulation of diagnostic kits for the specific pathogenic agent, or in general for the disease, including immunological disorders typical of so-called autoimmune diseases, with known or unknown etiology and/or pathogenesis; optional use of the selected phages and/or fragments thereof and/or their derivatives to induce a tolerance of the phenomena of hypersensitivity and/or allergy to compounds and/or natural or synthetic preparations; optional immunization of an organism by means of the selected phages and/or fragments thereof and/or their derivatives; and optional verification of the presence, in the serum of the immunized organism, of antibodies that recognize the above antigen or organism specific to the disease.
Patent DK-0760643-T3 (DK)
Inventor: BOBERG FREDRIK
IPC: A61F13/53
Filed: 1995-05-15
Granted: 2000-04-17
Abstract: PCT No. PCT/SE95/00538 Sec. 371 Date Jan. 22, 1997 Sec. 102(e) Date Jan. 22, 1997 PCT Filed May 15, 1995 PCT Pub. No. WO95/31162 PCT Pub. Date Nov. 23, 1995A disposable liquid-absorbing article, such as a diaper (10), sanitary towel or similar, having a substantially longitudinal shape and including an absorption body (12) and a cover (11) enclosing the absorption body with a liquid-pervious inner sheet (17) and an outer sheet (18) and contracting elastics members (23) in contact with at least one of the sheets to give the article its shape in an in-use position. The cover sheet on which the elastics members are applied, is connected to the inside and outside of the absorption body respectively, and the elastics members (23) extend with at least one substantially continually curved portion (24, 25) over at least an area of the absorption body. The strive of the elastics members to contract and the contact of the elastics members with one of the sheets, exert a tension force on the sheet in a direction towards the curvature center of the elastics members, whereby this force is transferred and absorbed by the absorption body.\!
Patent DK-0782452-T3 (DK)
Inventor: FISHMAN PNINA
IPC: C12N5/09
Filed: 1995-09-22
Granted: 2002-07-01
Abstract: A substance secreted or shed by muscle cells and white blood cells is disclosed. This novel substance is active in inhibiting proliferation of tumor cells and proliferation of stimulated lymphocytes. The substance does not inhibit proliferation of normal cells. This substance is used in accordance with the invention for treatment or prevention of cancer and the level of said substance in a body fluid or in a fluid conditioned by the growth therein of cells withdrawn from the individual, is used for the diagnosis of cancer or the level of risk of the individual of developing cancer.
Patent DK-0726024-T3 (DK)
Inventor: SCHEUFLER BERND DR
IPC: A01C15/00
Filed: 1996-02-02
Granted: 1998-12-07
Abstract: The method for controlling and regulating dosage levels in agricultural crop spraying, seed and fertiliser distribution according to position and area uses a computer (6) to store the necessary information. The computer extrapolates the future position of the agricultural vehicle from the current speed, and determines changes in the supply dispenser for turning the flow on or off, or changing the supply rate. The delay time of the supply dispenser is taken into account. On reaching the end of a field, the switch off is planned.
Patent DK-0897450-T3 (DK)
Inventor: CITTADINI PAOLO
IPC: B60J10/08
Filed: 1996-04-30
Granted: 2000-07-24
Abstract: A weather strip in particular for window and door frames having a base portion (2) arranged to be engaged in a respective anchoring area (3) of a first bearing frame (4). A head portion (5) of the weather strip is arranged to act against an abutment area (6) associated with the a second bearing frame (7). A band of magnetic material (8) is associated with the head portion, and there is an intermediate connecting portion (9) formed, in transverse section, by a single fillet element connecting the head portion with the base portion.